The authors determined two primary outcome measures, one evaluating cognitive function (SMMSE) and the other functional status, using the Bristol Activities of Daily Living Scale (BADLS).

The saga of Cassava Sciences' development of Alzheimer's disease therapy simufilam has come to its dismal end. The company has reported top-line data from a second phase 3 trial of the drug, which ...

Following the news of two lecanemab-related deaths reported on the eve of the Clinical Trials on Alzheimer’s Disease (CTAD) 2022 conference, Eisai has now presented the full results from its ...

Living well with chronic illness includes taking values-based action, not fighting against what you cannot control in the ...

Most patients experienced at least 10 symptoms and at least one aspect of emotional impact, such as worry, depression, or anxiety.

Strength and mobility are key to living independently as you age. A new book by an orthopedic surgeon and a trainer explain ...

All the latest breaking UK news with in-depth comment and analysis, pictures and videos from MailOnline and the Daily Mail.

Breaking science news and articles on global warming, extrasolar planets, stem cells, bird flu, autism, nanotechnology, dinosaurs, evolution -- the latest discoveries ...

June 21, 2025 — Researchers at ETH Zurich have developed an astonishing new material: a printable gel that’s alive. Infused with ancient cyanobacteria, this "photosynthetic living material ...